Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report
Frontiers in Pharmacology · 15.07.2026 · 17
DOI: 10.3389/fphar.2026.1848041 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.07.2026. Verfasst von Alifeila Aili und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical Universi…. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amiodarone-induced pulmonary toxicity (APT) has a broad clinical spectrum, and its radiologic and histopathologic appearances vary considerably. Granulomatous lung injury, however, is rarely described and may be confused with organizing pneumonia (OP) or infection. Case presentation An elderly man who had been receiving 5-month amiodarone therapy developed a 3-week history of pleuritic chest pain and progressive dyspnea. Chest computed tomography (CT) demonstrated bilateral ground-glass opacities and subpleural-predominant consolidations, with scattered reversed halo signs raising the possibility of an OP-like pattern. A positive serum Cryptococcal antigen (CrAg) result obtained at an outside hospital led to empiric antifungal therapy, but the patient did not improve. After admission, bronchoalveolar lavage (BAL) revealed lymphocytosis, and metagenomic testing did not detect Cryptococcus or other pathogens; fungal stains on biopsy specimens were also negative. Percutaneous lung biopsy showed focal non-necrotizing granulomas with prominent eosinophilic inflammation. After discontinuation of amiodarone and initiation of systemic corticosteroid therapy, his symptoms improved rapidly and follow-up imaging demonstrated interval regression.
Conclusion
This case illustrates that an OP-like CT pattern may mask an uncommon granulomatous phenotype of amiodarone-related lung injury. A positive fungal biomarker should therefore be weighed against the microbiological work-up, tissue findings, medication history, and treatment response before infection is accepted as the final diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Aili, A., Deng, H., Zhang, H., Wang, W., & Pan, L. (2026). Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1848041
Vancouver
Aili A, Deng H, Zhang H, Wang W, Pan L. Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1848041
BibTeX
@article{Aili2026,
author = {Aili, Alifeila and Deng, Hui and Zhang, Haopeng and Wang, Weiwei and Pan, Lei},
title = {Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1848041}
}
EUVIMED